Home Clinical Topics FDA approves new drug for hyperkalemia

FDA approves new drug for hyperkalemia

On Oct. 22, the U.S. Food and Drug Administration (FDA) approved eltassa (patiromer for oral suspension) to treat hyperkalemia. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here